Article Versions Notes

Froechlich G, Caiazza C, Gentile C, D’Alise AM, De Lucia M, Langone F, Leoni G, Cotugno G, Scisciola V, Nicosia A, et al. Integrity of the Antiviral STING-mediated DNA Sensing in Tumor Cells Is Required to Sustain the Immunotherapeutic Efficacy of Herpes Simplex Oncolytic Virus. Cancers. 2020; 12(11):3407. https://doi.org/10.3390/cancers12113407

Froechlich, Guendalina, Carmen Caiazza, Chiara Gentile, Anna Morena D’Alise, Maria De Lucia, Francesca Langone, Guido Leoni, Gabriella Cotugno, Vittorio Scisciola, Alfredo Nicosia, and et al. 2020. "Integrity of the Antiviral STING-mediated DNA Sensing in Tumor Cells Is Required to Sustain the Immunotherapeutic Efficacy of Herpes Simplex Oncolytic Virus" Cancers 12, no. 11: 3407. https://doi.org/10.3390/cancers12113407

Froechlich, G., Caiazza, C., Gentile, C., D’Alise, A. M., De Lucia, M., Langone, F., Leoni, G., Cotugno, G., Scisciola, V., Nicosia, A., Scarselli, E., Mallardo, M., Sasso, E., & Zambrano, N. (2020). Integrity of the Antiviral STING-mediated DNA Sensing in Tumor Cells Is Required to Sustain the Immunotherapeutic Efficacy of Herpes Simplex Oncolytic Virus. Cancers, 12(11), 3407. https://doi.org/10.3390/cancers12113407